Peptide API CMO Market: By Product Type (Peptide Generic API, Peptide NCEs), By Therapeutic area (Oncology, Cardiovascular Disorders, metabolic Disorders, CNS Disorders, Respiratory Disorders, Gastrointestinal Disorders, Anti-infective, Dermatology, Renal Disorders, Others), End User (Pharmaceutical Companies, Biopharmaceutical Companies) and Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Peptide API CMO Market was estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028. estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to increase in prevalence of various types of cancers, other chronic disorders. Moreover, rise in number of deaths due to diseases which do not possess complete cure with the conventional anticoccidial drugs, increasing demand for the R&D services by public and private sectors, increasing global geriatric population, and wide range of applications with the peptide API CMO are the major factors that are driving the growth of the global peptide API CMO market over the forecast timeframe.

   

Global Peptide Api Cmo Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Growth

Increase in the prevalence of cancer, autoimmune disorders, and other chronic diseases is a key factor drive the global peptide API CMO market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, product approval by the FDA for protein and peptide APIs, raise in funding for the R&D activities by public and private sectors are anticipated to propel the global peptide API CMO market over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Peptide Api Cmo Market Segmentation

Product Type
  • Peptide Generic API
  • Peptide NCEs
Therapeutic area
  • Oncology
  • Cardiovascular Disorders
  • metabolic Disorders
  • CNS Disorders
  • Respiratory Disorders
  • Gastrointestinal Disorders
  • Anti-infective
  • Dermatology
  • Renal Disorders
  • Others
End User
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
Geography
North America
  • US
  • Canada
Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Table of Content
  1. Executive Summary
  2. Global Peptide API CMO Market Introduction
    • Global Peptide API CMO Market – Taxonomy
    • Global Peptide API CMO Market –Definitions
      • Product Type
      • Therapeutic Area
      • End User
  1. Global Peptide API CMO Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Peptide API CMO Market Dynamic Factors - Impact Analysis
    • Global Peptide API CMO Market – Competition Landscape
  2. Global Peptide API CMO Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Peptide API CMO Market, By Product Type, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Peptide Generic API
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptide NCEs
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API CMO Market Forecast, By Therapeutic Area, 2015 - 2019 and Forecast, 2020 - 2026
    • Oncology
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiovascular Disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Metabolic Disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CNS Disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Respiratory Disorders
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Gastrointestinal Disorders
        • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Anti-infective Drugs
        • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Dermatology
        • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Renal Disorders
          • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
  1. Global Peptide API CMO Market Forecast, By End User, 2015 - 2019 and Forecast, 2020 - 2026
    • Pharmaceutical Companies
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Biopharmaceutical Companies
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Peptide API CMO Market Forecast, By Region, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Peptide API CMO Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Region, 2019 - 2025
  2. North America Peptide API CMO Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • By Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others
    • End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Peptide API CMO Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 - 2025
    • North America Peptide API CMO Market Dynamics – Trends
  3. Europe Peptide API CMO Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • By Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others
    • End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Peptide API CMO Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 - 2025
    • Europe Peptide API CMO Market Dynamics – Trends
  4. Asia-Pacific Peptide API CMO Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • By Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others
    • End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Peptide API CMO Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 - 2025
    • Asia-Pacific Peptide API CMO Market Dynamics – Trends
  5. Latin America Peptide API CMO Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • By Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others
    • End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Peptide API CMO Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 - 2025
    • Latin America Peptide API CMO Market Dynamics – Trends
  6. Middle East and Africa Peptide API CMO Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • By Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Peptide Generic API
      • Peptide NCEs
    • Therapeutic Area Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oncology
      • Cardiovascular Disorders
      • metabolic Disorders
      • CNS Disorders
      • Respiratory Disorders
      • Gastrointestinal Disorders
      • Anti-infectives
      • Dermatology
      • Renal Disorders
      • Others
    • End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Peptide API CMO Market - Opportunity Analysis Index, By Product Type, Therapeutic Area, End User, and Country, 2019 - 2025
    • MEA Peptide API CMO Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Therapeutic Area & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • ScinoPharm Taiwan, Ltd. (Taiwan)
      • Corden Pharma International (Germany)
      • Bachem AG (Switzerland)
      • Biopeptek Pharmaceuticals LLC. (U.S.)
      • Hybio Pharmaceutical Co., Ltd. (China)
      • Chinese Peptide Company (China)
      • AmbioPharm, Inc. (U.S.)
      • Teva Pharmaceutical Industries Ltd. (Israel)
      • PolyPeptide Group (Sweden)
      • Chemi S.p.A. (Italy)
  1. Research Methodology
Key Assumptions and Acronyms

Competition Assessment

  • ScinoPharm Taiwan, Ltd. (Taiwan)
  • Corden Pharma International (Germany)
  • Bachem AG (Switzerland)
  • Biopeptek Pharmaceuticals LLC. (U.S.)
  • Hybio Pharmaceutical Co., Ltd. (China)
  • Chinese Peptide Company (China)
  • AmbioPharm, Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • PolyPeptide Group (Sweden)
  • Chemi S.p.A. (Italy)